Stock of the Day

March 23, 2021

Cooper Companies (COO)

$58.06
+$0.66 (+1.1%)
Market Cap: $11.00B

About Cooper Companies

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Today's Trend

The Cooper Companies, Inc. (NASDAQ: COO) is seeing mixed investor signals. A Barclays upgrade and better-than-expected earnings per share are supportive, but multiple securities-investigation announcements and a sharply reduced consensus price target are weighing on sentiment. The stock remains well below its 12-month high of $89.83.

  • Barclays upgraded COO to “Hold.” The move from a more negative rating removes some pressure on the shares, although “Hold” still indicates limited near-term upside in the bank’s view. Cooper Companies Stock Rating Raised to Hold at Barclays
  • Cooper’s latest earnings included an EPS beat. The company reported quarterly EPS of $1.15, above the $1.12 analyst consensus, while full-year 2026 guidance remains centered near $4.53 per share. This suggests profitability is holding up despite operational concerns. Why Is The Cooper Companies Up Since Last Earnings Report?
  • Post-earnings trading has been relatively stable. A review of the period since the September 9 earnings report notes only a modest change in the stock, reflecting investor uncertainty after revenue of $1.07 billion came in below the $1.10 billion consensus estimate. Revenue growth was only 0.5% year over year.
  • Several law firms are investigating potential securities claims. Rosen Law Firm issued another investor notice, following separate Rosen and Pomerantz announcements, alleging that Cooper may have provided materially misleading business information. These notices do not establish wrongdoing, but they add litigation risk and can pressure the valuation. Rosen Investor Investigation
  • The consensus price target was reduced by 17.87% to MX$1,180.28. The cut signals that analysts have lowered their expectations for COO’s fair value, likely reflecting weaker growth expectations and ongoing uncertainty.

Recent News